Aug 25
|
This Quipt Home Medical Insider Increased Their Holding In The Last Year
|
Jul 31
|
Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2024 Financial Results on August 14, 2024
|
Jul 23
|
Quipt Home Medical (TSE:QIPT) Is Doing The Right Things To Multiply Its Share Price
|
Jun 26
|
Institutional investors own a significant stake of 49% in Quipt Home Medical Corp. (TSE:QIPT)
|
May 15
|
Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10% and Adjusted EBITDA Growth of 14%
|
May 9
|
Quipt Home Medical Corp. Announces Filing of Final Base Shelf Prospectus
|
May 6
|
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024
|
May 2
|
Quipt Home Medical Announces Normal Course Issuer Bid
|
Apr 15
|
Quipt Home Medical (TSE:QIPT) shareholders have endured a 42% loss from investing in the stock a year ago
|
Mar 28
|
Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders
|
Mar 12
|
Quipt Home Medical Announces Participation in the 36th Annual Roth Investor Conference on March 17-19, 2024
|
Feb 16
|
Quipt Home Medical Corp. (NASDAQ:QIPT) Q1 2024 Earnings Call Transcript
|
Feb 1
|
Quipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024
|
Dec 27
|
Quipt Home Medical Corp. Announces Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus
|
Dec 18
|
Quipt Home Medical Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results Posting Revenue Growth of 59% and Adjusted EBITDA Growth of 73%
|
Dec 5
|
Quipt Home Medical Corp. to Announce Fourth Quarter and Full Year 2023 Financial Results on December 18, 2023
|
May 2
|
Quipt Home Medical Receives Conditional Approval to Graduate to the Toronto Stock Exchange
|
Apr 29
|
TSX Venture Exchange Stock Maintenance Bulletins
|
Feb 14
|
Quipt Home Medical Reports Record First Quarter Fiscal 2023 Financial Results Posting Positive Net Income, Revenue Growth of 38% and Adjusted EBITDA Growth of 50%
|